REG - Iconic Labs PLC - Restoration of Trading and Funding Update

Iconic LabsAnnouncement

20/05/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250520:nRST2730Ja&default-theme=true

RNS Number : 2730J  Iconic Labs PLC  20 May 2025

 

Iconic Labs PLC

 

("Iconic" or the "Company")

 

Restoration of Trading and Funding Update

 

Iconic Labs PLC (LSE:ICON) has requested the Financial Conduct Authority to
lift the suspension of the listing of the Company's Ordinary Shares and as a
result, shareholders can once again trade in the Company's shares on the
London Stock Exchange as of 20 May 2025.

 

The Directors will continue to search for a new acquisition target and will
update the market when it is in a position to do so.

 

As at 30 April 2025, Iconic had around £100,000 of external trade
creditors/accrued expenses.  ABO, the Company's key funding partner, through
its WTGO fund, has confirmed that they will fund this amount and continue to
fund Iconic on a rolling three-month basis as Iconic searches for alternative
acquisition targets.

 

In the event that a target cannot be identified in a reasonable time frame, it
is possible that the Company's investor, ABO, will cease to provide such
funding.  Although the Directors would endeavour to pursue alternative
sources of funding, there is no certainty that this would be achieved. In
such an event Iconic would need to wind down its operations, realise any
assets and may enter administration, if and to the extent there are creditors
of the Company who cannot be paid. In such an event, Iconic would no longer
manage its affairs or the realisation of its assets. As a result of either
winding down the business or entering into administration, the Ordinary Shares
would be cancelled from the Official List and Shareholders may receive little
or no value for their Ordinary Shares.

 

 

 

- Ends -

 

For more information, please contact:

 Iconic Labs                                         via Yellow Jersey PR

 John Farquharson, Interim Chief Executive Officer
 Novum Securities Limited                            Tel: +44 (0) 20 7399 9400

 David Coffman / Daniel Harris
 Yellow Jersey PR                                    Tel: +44 (0) 20 3004 9512

 Charles Goodwin

 Annabelle Wills                                     iconic@yellowjerseypr.com

 Bessie Elliot

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTBUGDURBBDGUC